Overview
In representing clients in transactional and corporate matters, Peter Schaeffer has experience in the full range of issues faced by public and private companies. His transactional practice focus is in the areas of private equity, venture capital and mergers and acquisitions. His practice also includes ongoing representation of publicly traded corporations and privately held companies, including advice in regard to disclosure and compliance under the Securities Act of 1933 and the Securities Exchange Act of 1934, as well as requirements under the Sarbanes-Oxley Act.
Mr. Schaeffer often advises private equity and venture investors in their investments. He also represents early stage companies on formation issues, equity and compensation matters, licensing and in their venture capital and other financings. Mr. Schaeffer has represented several companies in their initial public offerings as well as in secondary offerings, PIPES, joint ventures and in the establishment of credit facilities. He represents clients in critical contract issues such as manufacturing and supply agreements, license agreements and employment and consulting agreements.
Representative Matters
Ongoing representation of $4 billion private equity firm in private equity and venture capital investments.
Representation of manufacturing company in the $200 million sale of one of its operating divisions.
Represented public fuel-cell manufacturing company in connection with private placement and public offering of shares and significant strategic transactions.
Represented education company in its corporate formation issues and in its issuance of shares to leading venture capital investors.
Represented the special committee of public healthcare technology company in connection with the sale of the company to private equity buyer.
Represented education company in its IPO, acquisitions, dispositions, strategic alliances and PIPE financings.
Represented a technology healthcare company in its IPO, acquisitions, several strategic alliances with major media companies, venture capital financings, and the acquisition of it through a merger with another publicly traded company.
Represented premium spirits company in its initial public offering and in prior financing transactions.
Represented CME and medical publishing business in its $350 million private equity sale.
Represented consumer product company in connection with its acquisition of the global consumer product division of a multinational corporation and the simultaneous venture investment in, and bank financing of, this client.
Represented leading book publishing company in its acquisition of a publishing imprint in a bankruptcy transaction involving multiple bidders.
Represent fashion client in the disposition of his business to private equity investors and separate sale of real estate interests.
Represented medical publishing company in its dispositions of each of its medical publishing and contract research organization businesses and in its related dissolution. Prior representation of this client in various venture financings, bank financings, debt restructurings and acquisitions and strategic transactions.
Represented Fortune 100 pharmaceutical company in connection with the disposition of assets in connection with the settlement of litigation.
Represented public life sciences company in connection with its PIPE transaction and restructuring.
Ongoing advice with the firm’s pro bono efforts, especially in connection with coordinating corporate associates’ involvement with various micro-entrepreneur pro bono clients.